• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[将治疗性研究推广作为一个开放的规划过程的准备工作]

[Preparation of the promotion of therapeutic studies as an open planning process].

作者信息

Heeg S, Fliedner T M

出版信息

Z Rheumatol. 1983 Nov-Dec;42(6):370-5.

PMID:6364624
Abstract

During the preparation of the government program "Health Research and Development", which was started in 1978, an attempt was made to involve the scientific community directly in establishing priorities for research on rheumatic diseases. At a planning conference open to all interested research scientists the following questions were considered: 1. What are the methodological requirements for therapeutic trials? 2. What are the open questions in the field of clinical rheumatology and which of them should be given priority? 3. What are the conditions for running multicenter therapeutic trials successfully? This paper describes the methodology and the results of the analysis of research needs and priorities and discusses the special problems of clinical rheumatology research in the Federal Republic of Germany.

摘要

在1978年启动的政府项目“健康研究与发展”的筹备过程中,曾尝试让科学界直接参与确定风湿病研究的优先事项。在一次对所有感兴趣的研究科学家开放的规划会议上,讨论了以下问题:1. 治疗试验的方法学要求有哪些?2. 临床风湿病领域存在哪些未解决的问题,其中哪些应优先考虑?3. 成功开展多中心治疗试验的条件是什么?本文描述了研究需求和优先事项分析的方法及结果,并讨论了德意志联邦共和国临床风湿病研究的特殊问题。

相似文献

1
[Preparation of the promotion of therapeutic studies as an open planning process].[将治疗性研究推广作为一个开放的规划过程的准备工作]
Z Rheumatol. 1983 Nov-Dec;42(6):370-5.
2
The NCI All Ireland Cancer Conference.美国国家癌症研究所全爱尔兰癌症会议。
Oncologist. 1999;4(4):275-277.
3
[Research planning without regimentation. Concept of "open research planning" with the example of the Federal Government Program "Research and development in the service of health"].
MMW Munch Med Wochenschr. 1982 Oct 1;124(39):845-8.
4
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
5
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
6
Family planning training and community needs.计划生育培训与社区需求。
Child Trop. 1983(141):2-3, 7-46.
7
Expert Group Meeting on Family Planning, Health and Family Well-Being.计划生育、健康与家庭幸福专家小组会议
Popul Bull UN. 1993(34-35):79-101.
8
[Priority trends in scientific research on the problem of ischemic disorders of cerebrovascular circulation].[脑血管循环缺血性疾病问题的科学研究优先趋势]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1990;90(1):3-8.
9
Experience of King Abdul-Aziz City for science and technology in funding medical research in Saudi Arabia.阿卜杜勒-阿齐兹国王科技城在沙特阿拉伯资助医学研究的经验。
Saudi Med J. 2004 Jan;25(1 Suppl):S8-12.
10
[The PAL+ program, an incentive concerted action about malaria and associated infectious diseases, for developing countries].[针对发展中国家的疟疾及相关传染病的激励性协同行动——PAL+项目]
J Soc Biol. 2004;198(3):207-11.